Advanced search
Publication Cover
Journal of Medical Economics Volume 10, 2007 - Issue 2
Submit an article Journal homepage
346
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Estimating the rates of disability progression in people with active relapsing-remitting multiple sclerosis

Ray Gani Heron Evidence Development, Letchworth Garden City, UKCorrespondence[email protected]
, PhD,
Richard M Nixon MRC Biostatistics Unit, Cambridge, UK
, PhD,
Steve Hughes Biogen Idec, Maidenhead, UK
, MRCP &
Chris H Jackson Division of Epidemiology, Imperial College London, UK
, PhD
Pages 79-89 | Accepted 27 Feb 2007, Published online: 01 Jan 2007

References

  • Richards RG, Sampson FC, Beard SM, Tappenden P. A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technology Assessment 2002; 6: 1–73.
  • Quarles RH, Morell P, McFarland HF. Diseases involving myelin. In: Basic Neurochemistry (7th Edition), Elsevier, 2006: 639–652.
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.
  • Tyas DA, Kerrigan J, Russell N, Nixon R. The distribution of the cost of multiple sclerosis in the UK: how do costs vary by illness severity? Value in Health (in press).
  • Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. New England Journal of Medicine 2000; 343: 1430–1438.
  • Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770–782. 7. Ebers GC. Natural history of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2001; 71 (Suppl 2): ii16–ii19.
  • Weinshenker BG, Bass B, Rice GP et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain. 1989; 112 (Pt 6): 1419–1428.
  • Cottrell DA, Kremenchutzky M, Rice GP et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999; 122 (Pt 4): 625–639.
  • Tappenden P, Chilcott J, O’Hagan. Cost effectiveness of beta interferons and glatiramer acetate in the management of multiple sclerosis. 2001. Centre for Bayesian Statistics in Health Economics, School of Health and Related Research (ScHARR).
  • Polman CH, O’Connor PW, Havrdova E et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. New England Journal of Medicine. 2006; 354: 899–910.
  • Draft II EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR). TYSABRI. EPAR summary for the public. EMEA/H/C/603, 1–38. 2006. European Medicines Agency.
  • Jackson CH, Sharples LD, Thompson SG, Duffy SW, Couto E. Multistate Markov models for disease progression with classification error. Journal of the Royal Statistical Society 2003; 52: 193–209.
  • Gentleman RC, Lawless JF, Lindsey JC, Yan P. Multi-state Markov models for analysing incomplete disease history data with illustrations for HIV disease. Statistics in Medicine 1994; 13: 805–821.
  • Longini IM Jr, Clark WS, Byers RH et al. Statistical analysis of the stages of HIV infection using a Markov model. Statistics in Medicine 1989; 8: 831–843.
  • Andersen PK. Multistate models in survival analysis: a study of nephropathy and mortality in diabetes. Statistics in Medicine 1988; 7: 661–670.
  • Duffy SW, Chen HH, Tabar L, Day NE. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statistics in Medicine 1995; 14: 1531–1543.
  • The R Project for Statistical Computing. The GNU Operating System. Association of British Neurologists. Guidelines for the use of beta interferons and glatiramer acetate in multiple Sclerosis. 1-12. 2001. London, Association of British Neurologists.
  • Weinshenker BG, Bass B, Rice GP et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989; 112 (Pt 1): 133–146.
  • Pokorski RJ. Long-term survival experience of patients with multiple sclerosis. Journal of Insurance Medicine 1997; 29: 101–106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.